Clinical Trials Directory

Trials / Completed

CompletedNCT04376671

Quantitative EEG Markers in Mild Cognitive Impairment in Epilepsy

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Mansoura University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Epileptic patients are plighted with limited daily activities, social dysfunction, family conflicts and cognitive impairment. Most of the studies had showed that cognitive disorders were frequent in patients with epilepsy.The cognitive impairment has been reported in around 25% of epileptic patients.

Detailed description

Cognitive consequences in epilepsy are often described in the following domains: verbal memory, language, executive functions, and attention. However, most of the studies focus on one or two domains in a relatively small sample. Few studies have investigated the influential factors for the epilepsy-related cognitive impairment . However, most of these studies merely focused on one or a few potential factors and failed to consider possible distractions from other influential factors. Therefore, it is crucial to include more potential factors in the analysis and to rule out possible confounding interactions between factors.

Conditions

Interventions

TypeNameDescription
DEVICEElectroencephalographyThe patients underwent EEG recordings according to previously published methods (Bonanni et al., 2008). . EEG recordings were analyzed with methods described in our previous work (Bonanni et al., 2008) by 2 experimenters unaware of the clinical conditions of the subjects. Briefly, quantitative EEGs (QEEGs) were recorded from 21 scalp derivations. Ag/AgCl disk scalp electrodes (19) were placed according to the international 10-20 system, EEG was recorded from Fp1, Fp2, Fz, F3, F4, F7, F8, Cz, C3, C4, Pz, P3, P4, T3, T 4, T5, T6, O1, and O2. Two additional electrodes were placed on A1 and A2. EEG activity was analyzed from single or multiple leads grouped to define the following scalp regions: anterior (Fz, Fp2, F7, Fp1, F3, F4, and F8), central (Cz, C3, and C4), posterior (Pz, P3, P4, O1, and O2), and temporal (T3, T4, T5, and T6).

Timeline

Start date
2019-03-01
Primary completion
2020-02-01
Completion
2020-03-01
First posted
2020-05-06
Last updated
2020-05-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04376671. Inclusion in this directory is not an endorsement.